Organometallics
Article
−0.3, −0.6, −0.6, −0.9. HRMS: calcd for C13H30O3Si4 + H, 347.1350;
found 347.1346.
(75 MHz, CDCl3): 162.2, 147.2, 145.8, 145.0, 144.2, 133.4, 133.1,
128.3, 128.2, 128.1, 126.5, 126.3, 0.0, −0.5.
3-(Cyclohexylmethyl)-2,2,5,5-tetramethyl-2,5-dihydro-1,2,5-oxa-
disilole (17a). 1H NMR (300 MHz, CDCl3): 6.48 (s, 1H), 2.18 (br d,
J = 7.0 Hz, 2H), 1.75−1.62 (m, 5H), 1.45−1.35 (m, 1H), 1.29−1.11
(m, 3H), 0.92−0.78 (m, 2H), 0.21 (s, 6H), 0.19 (s, 6H). 13C NMR
(75 MHz, CDCl3): 167.6, 144.7, 45.0, 36.9, 33.5, 26.6, 26.3, 1.0, 0.5.
MS (EI): 254 (M+, 2), 239 (M+ − Me, 16), 172 (22), 157 (46), 133
(33), 83 (45), 73 (34), 55 (100).
1,1,4,4-Tetramethyl-2-(p-tolyl)-1,4-dihydrobenzo[b][1,4]disiline
1
(7e). H NMR (300 MHz, CDCl3): 7.64−7.58 (m, 2H), 7.43−7.36
(m, 2H), 7.17 (d, J = 7.0 Hz, 2H), 7.15 (d, J = 7.0 Hz, 2H), 6.84 (s,
1H), 2.37 (s, 3H), 0.38 (s, 6H), 0.36 (s, 6H). 13C NMR (75 MHz,
CDCl3): 161.9, 145.1, 145.1, 144.3, 144.2, 136.1, 133.3, 133.1, 128.9,
128.3, 128.1, 126.2, 21.1, 0.1, −0.5. HRMS: calcd for C19H24Si2 + H,
309.1495; found 309.1490.
2-(2-Methoxyphenyl)-1,1,4,4-tetramethyl-1,4-dihydrobenzo[b]-
2,2,5,5-Tetraphenyl-3-(prop-1-en-2-yl)-2,5-dihydro-1,2,5-oxadisi-
1
1
[1,4]disiline (8e). H NMR (300 MHz, CDCl3): 7.63−7.57 (m, 2H),
lole (19b). H NMR (300 MHz, CDCl3): 7.69 (d, J = 7.0 Hz, 4H),
7.44−7.36 (m, 2H), 7.22 (dd, J1 = 7.5 Hz, J2 = 2.0 Hz, 1H), 7.04 (dd,
J1 = 7.5 Hz, J2 = 2.0 Hz, 1H), 6.93 (t, J = 7.5 Hz, 1H), 6.85 (d, J = 7.5
Hz, 1H), 6.84 (s, 1H), 3.82 (s, 3H), 0.39 (s, 6H), 0.30 (s, 6H). 13C
NMR (75 MHz, CDCl3): 161.4, 155.3, 147.0, 146.1, 144.5, 136.8,
133.0, 132.9, 128.9, 128.1, 127.9, 127.7, 121.0, 109.8, 54.7, −0.6, −0.6.
HRMS: calcd for C19H24OSi2 + H, 325.1443; found 325.1433.
2-(4-Fluorophenyl)-1,1,4,4-tetramethyl-1,4-dihydrobenzo[b][1,4]-
7.62 (d, J = 7.0 Hz, 4H), 7.49−7.35 (m, 12H), 7.28 (s, 1H), 5.19 (br s,
1H), 5.14 (br s, 1H), 2.03 (s, 3H). 13C NMR (75 MHz, CDCl3):
164.3, 144.2, 142.7, 135.2, 134.8, 134.6, 134.4, 130.3, 130.3, 127.9,
127.9, 120.1, 20.5. HRMS: calcd for C29H26OSi2 + H, 447.1600; found
447.1591.
3-(2,2-Diphenylcyclopropyl)-2,2,5,5-tetramethyl-2,5-dihydro-
1,2,5-oxadisilole (22a). 1H NMR (300 MHz, CDCl3): 7.28−7.07 (m,
10H), 5.84 (s, 1H), 2.46 (dd, J1 = 8.0 Hz, J2 = 7.5 Hz, 1H), 1.85 (dd, J1
= 8.5 Hz, J2 = 8.0 Hz, 1H), 1.59 (dd, J1 = 8.5 Hz, J2 = 7.5 Hz, 1H), 0.26
(s, 3H), 0.11 (s, 6H), −0.13 (s, 3H). 13C NMR (75 MHz, CDCl3):
163.5, 146.8, 142.6, 140.2, 131.2, 128.4, 127.9, 127.7, 126.2, 126.0,
41.0, 30.1, 20.8, 0.6, 0.4, 0.4, −0.0. MS (EI): 350 (M+, 11), 258 (12),
133 (100), 73 (44).
Ethyl 2,4,5-Trimethyl-2,5-bis((trimethylsilyl)oxy)-2,5-dihydro-
1,2,5-oxadisilole-3-carboxylate (26c). 1H NMR (300 MHz,
CDCl3): 4.27−4.14 (m, 2H), 2.22 and 2.21 (two singlets, 3H each,
corresponding to the two diastereomers), 1.31 (t, J = 7.5 Hz, 3H),
0.30, 0.26, 0.23, and 0.19 (four singlets, 3H each, corresponding to the
two diastereomers), 0.11, 0.10, 0.09, and 0.07 (four singlets, 9H each,
corresponding to the two diastereomers). 13C NMR (75 MHz, CDCl3,
equimolar mixture of two diastereomers): 172.3. 172.2, 167.2, 167.2,
144.8, 144.8, 59.7, 59.7, 17.3, 17.2, 14.3, 14.3, 1.7, 1.6, 1.6, 1.6, −0.8,
−1.2, −2.4, −2.7. HRMS: calcd for C14H32O5Si4 + H, 393.1405; found
393.1399.
2,2,4,4,7,7-Hexamethyl-5-(p-tolyl)-4,7-dihydro-1,3,2,4,7-dioxatri-
silepine (7d). 1H NMR (300 MHz, CDCl3): 7.10 (d, J = 8.0 Hz, 2H),
7.00 (d, J = 8.0 Hz, 2H), 6.33 (s, 1H), 2.34 (s, 3H), 0.26 (s, 6H), 0.22
(s, 6H), 0.16 (s, 6H). 13C NMR (75 MHz, CDCl3): 164.0, 147.1,
145.2, 135.7, 128.7, 126.3, 21.0, 1.6, 1.3, 0.7. HRMS: calcd for
C15H26O2Si3 + H, 323.1319; found 323.1314.
1
disiline (11e). H NMR (300 MHz, CDCl3): 7.64−7.58 (m, 2H),
7.43−7.37 (m, 2H), 7.23−7.18 (m, 2H), 7.02 (t, J = 8.5 Hz, 2H), 6.83
(s, 1H), 0.36 (s, 6H), 0.36 (s, 6H). 13C NMR (75 MHz, CDCl3):
161.8 (d, JC−F = 243.5 Hz), 161.1, 146.0 (d, JC−F = 1.0 Hz), 144.7,
144.0, 143.2 (d, JC−F = 3.0 Hz), 133.4, 133.1, 128.4, 128.2, 127.9 (d,
JC−F = 8.0 Hz), 115.0 (d, JC−F = 21.0 Hz), 0.0, −0.5. HRMS: calcd for
C18H21FSi2 + H, 313.1244; found 313.1235.
1,1,4,4-Tetramethyl-2-pentyl-1,4-dihydrobenzo[b][1,4]disiline
32
1
(13e) (ref ). H NMR (300 MHz, CDCl3): 7.60−7.54 (m, 2H),
7.40−7.33 (m, 2H), 6.57 (s, 1H), 2.30 (br t, J = 6.5 Hz, 2H), 1.52−
1.44 (m, 2H), 1.39−1.26 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H), 0.31 (s,
6H), 0.27 (s, 6H). 13C NMR (75 MHz, CDCl3): 162.4, 145.0, 144.8,
140.4, 133.1, 133.0, 128.0, 127.9, 40.0, 31.7, 28.3, 22.6, 14.1, −0.4,
−0.8.
2-Cyclopropyl-1,1,4,4-tetramethyl-1,4-dihydrobenzo[b][1,4]-
1
disiline (15e). H NMR (300 MHz, CDCl3): 7.62−7.54 (m, 2H),
7.41−7.35 (m, 2H), 6.30 (s, 1H), 0.39 (s, 6H), 0.26 (s, 6H). 13C NMR
(75 MHz, CDCl3): 162.9, 144.8, 144.7, 134.1, 133.2, 133.1, 128.1,
128.0, 18.0, 7.0, −0.3, −0.9. HRMS: calcd for C15H22Si2 + H,
259.1338; found 259.1334.
Ethyl 1,1,4,4-Tetramethyl-1,4-dihydrobenzo[b][1,4]disiline-2-car-
1
boxylate (23e). H NMR (300 MHz, CDCl3): 8.02 (s, 1H), 7.62−
7.55 (m, 2H), 7.44−7.36 (m, 2H), 4.28 (q, J = 7.0 Hz, 2H), 1.37 (t, J =
7.0 Hz, 3H), 0.43 (s, 6H), 0.34 (s, 6H). 13C NMR (75 MHz, CDCl3):
168.4, 159.1, 150.3, 144.7, 142.6, 133.7, 133.1, 128.5, 128.2, 60.7, 14.3,
−0.2, −1.0. HRMS: calcd for C15H22O2Si2 + H, 291.1236; found
291.1231.
5-(2-Methoxyphenyl)-2,2,4,4,7,7-hexamethyl-4,7-dihydro-
1
1,3,2,4,7-dioxatrisilepine (8d). H NMR (300 MHz, CDCl3): 7.19
(dt, J1 = 7.5, J2 = 2.0 Hz, Hz, 1H), 7.04 (dd, J1 = 7.5 Hz, J2 = 2.0 Hz,
1H), 6.92 (dt, J1 = 7.5 Hz, J2 = 1.0 Hz, 1H), 6.77 (br d, J = 7.5 Hz,
1H), 6.37 (s, 1H), 3.76 (s, 3H), 0.27 (s, 6H), 0.17 (s, 6H), 0.14 (s,
6H). 13C NMR (75 MHz, CDCl3): 162.7, 155.0, 147.2, 138.2, 128.5,
127.7, 121.0, 109.6, 54.4, 1.4, 1.0, 0.8. HRMS: calcd for C15H26O3Si3 +
H, 339.1268; found 339.1262.
Ethyl 1,1,3,4,4-Pentamethyl-1,4-dihydrobenzo[b][1,4]disiline-2-
carboxylate (26e). 1H NMR (300 MHz, CDCl3): 7.60−7.53 (m,
2H), 7.41−7.36 (m, 2H), 4.28 (q, J = 7.5 Hz, 2H), 2.09 (s, 3H), 1.35
(t, J = 7.5 Hz, 3H), 0.37 (s, 6H), 0.35 (s, 6H). 13C NMR (75 MHz,
CDCl3): 170.6, 158.6, 146.3, 143.7, 143.2, 133.1, 133.0, 128.4, 128.3,
60.2, 21,0, 14.5, −0.7, −1.8. HRMS: calcd for C16H24O2Si2 + H,
305.1393; found 305.1388.
5-(4-Fluorophenyl)-2,2,4,4,7,7-hexamethyl-4,7-dihydro-1,3,2,4,7-
1
dioxatrisilepine (11d). H NMR (300 MHz, CDCl3): 7.09−6.93 (m,
4H), 6.32 (s, 1H), 0.26 (s, 6H), 0.20 (s, 6H), 0.15(s, 6H). 13C NMR
(75 MHz, CDCl3): 163.1, 161.6 (d, JC−F = 245.0 Hz), 148.0 (d, JC−F
=
ASSOCIATED CONTENT
1.0 Hz), 144.1 (d, JC−F = 3.5 Hz), 127.9 (d, JC−F = 8.0 Hz), 114.8 (d,
JC−F = 21.0 Hz), 1.5, 1.3, 0.7. HRMS: calcd for C14H23FO2Si3 + H,
327.1068; found 327.1063.
2,2,4,4,7,7-Hexamethyl-5-pentyl-4,7-dihydro-1,3,2,4,7-dioxatrisi-
lepine (13d). 1H NMR (300 MHz, CDCl3): 6.15 (s, 1H), 2.10 (t, J =
6.5 Hz, 2H), 1.52−1.35 (m, 6H), 0.89 (t, J = 7.0 Hz, 3H), 0.19 (s,
6H), 0.18 (s, 6H), 0.09 (s, 6H). 13C NMR (75 MHz, CDCl3): 163.2,
142.1, 40.3, 31.7, 29.1, 22.5, 14.0, 1.4, 1.0, 0.7. HRMS: calcd for
C13H30O2Si3 + H, 303.1632; found 303.1626.
Ethyl 2,2,4,4,6,7,7-heptamethyl-4,7-dihydro-1,3,2,4,7-dioxatrisile-
pine-5-carboxylate (26d). 1H NMR (300 MHz, CDCl3): 4.19 (q, J =
7.0 Hz, 2H), 1.80 (s, 3H), 1.30 (t, J = 7.0 Hz, 3H), 0.25 (s, 6H), 0.24
(s, 6H), 0.11 (s, 6H). 13C NMR (75 MHz, CDCl3): 172.6, 155.0,
149.1, 60.2, 21.1, 14.3, 0.9, 0.5, 0.1. HRMS: calcd for C12H26O4Si3 + H,
319.1217; found 319.1213.
1,1,4,4-Tetramethyl-2-phenyl-1,4-dihydrobenzo[b][1,4]disiline
(6e) (ref 32). 1H NMR (300 MHz, CDCl3): 7.64−7.56 (m, 2H),
7.44−7.25 (m, 7H), 6.87 (s, 1H), 0.39 (s, 6H), 0.38 (s, 6H). 13C NMR
■
S
* Supporting Information
1
Copies of H and 13C NMR spectra of all products. This
material is available free of charge via the Internet at http://
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank ProFI (ITE, Heraklion, Greece) for obtaining the
HRMS spectra. Two of the authors (I.N.L. and M.S.) deeply
■
G
dx.doi.org/10.1021/om3011678 | Organometallics XXXX, XXX, XXX−XXX